Recombinant CA9 (Girentuximab Biosimilar) 抗体
This anti-CA9 (Girentuximab Biosimilar) antibody is a Human Chimeric antibody detecting CA9 (Girentuximab Biosimilar) in ELISA, WB. Suitable for Human.
Quick Overview for Recombinant CA9 (Girentuximab Biosimilar) 抗体 (ABIN7538057)
抗原
CA9 (Girentuximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human, 小鼠
克隆类型
Chimeric
标记
This CA9 (Girentuximab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Girentuximab Biosimilar - Anti-CA9 mAb - Research Grade
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG1 kappa
-
-
anti-CA9 (Girentuximab Biosimilar) antibody
Research Grade 适用: 人 ELISA, FACS 宿主: 小鼠 Chimeric unconjugated Recombinant Antibody
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CA9 (Girentuximab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Recombinant chimeric antibody binding to human CA9. Girentuximab is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.
-
CAS-编号
- 916138-87-9
抗原
-
You are here:
